Evidence map›Paper›PMID 28083133›Full record

ArticleActa crystallographica. Section E, Crystallographic communications2017

Crystal structure of 2-oxo-2

Eric Ziki, Siaka Sosso, Frédérica Mansilla-Koblavi, Abdoulaye Djandé, Rita Kakou-Yao

Abstract read
In one paragraph

Article in Acta crystallographica. Section E, Crystallographic communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Synthesis, structure and Hirshfeld surface analysis of 2-oxo-2Acta crystallographica. Section E, Crystallographic communications · 2024
    Article
  2. 2-Oxo-2IUCrData · 2024
    Article
  3. Synthesis, structure and Hirshfeld surface analysis of 2-oxo-2Acta crystallographica. Section E, Crystallographic communications · 2024
    Article
  4. The crystal structures of two new coumarin derivatives: 2-(4-{2-[(2-oxo-2Acta crystallographica. Section E, Crystallographic communications · 2019
    Article
  5. Crystal structure of 2-oxo-2Acta crystallographica. Section E, Crystallographic communications · 2018
    Article
  6. 2-Oxo-2Acta crystallographica. Section E, Crystallographic communications · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eric ZikiLaboratoire de Cristallographie et Physique Moléculaire, UFR SSMT, Université Félix Houphouët Boigny de Cocody 22 BP 582 Abidjan 22, Côte d'Ivoire.
Siaka SossoLaboratoire de Chimie Moléculaire et Matériaux, Equipe de Chimie Organique et Phytochimie, Université Ouaga I Pr Joseph KI-ZERBO 03 BP 7021 Ouagadougou 03, Burkina Faso.
Frédérica Mansilla-KoblaviLaboratoire de Cristallographie et Physique Moléculaire, UFR SSMT, Université Félix Houphouët Boigny de Cocody 22 BP 582 Abidjan 22, Côte d'Ivoire.
Abdoulaye DjandéLaboratoire de Chimie Moléculaire et Matériaux, Equipe de Chimie Organique et Phytochimie, Université Ouaga I Pr Joseph KI-ZERBO 03 BP 7021 Ouagadougou 03, Burkina Faso.
Rita Kakou-YaoLaboratoire de Cristallographie et Physique Moléculaire, UFR SSMT, Université Félix Houphouët Boigny de Cocody 22 BP 582 Abidjan 22, Côte d'Ivoire.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the title compound, C

Indexed as

chromanecrystal structureHirshfeld surface analysishydrogen bondquantum-chemical calculationsπ–π inter­actions

Identifiers

PMID28083133
PMCPMC5209769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.